Reactive oxygen species and antioxidant defense in puromycin aminonucleoside glomerulopathy.
Results from several radical scavenger studies indirectly suggested an involvement of reactive oxygen species in the pathogenesis of puromycin aminonucleoside glomerulopathy. In this study, generation of reactive oxygen species was examined directly in glomeruli isolated from rats in the acute phase of puromycin aminonucleoside nephrosis and related to the changes in the glomerular antioxidant defense. Five and nine days after puromycin aminonucleoside injection, gross proteinuria, reduced creatinine clearances, and typical changes of glomerular morphology were present. Levels of reactive oxygen species were increased eightfold in glomeruli isolated 15 min after puromycin aminonucleoside injection, returned to baseline levels on days 1 and 5 after injection, and rose again to 14-fold on day 9 after injection, as determined by chemiluminescence with luminol. Further analysis of increased glomerular radical generation, using the chemiluminescence enhancer lucigenin and different radical scavengers, suggested a predominant involvement of hydroxyl radical and hydrogen peroxide in the initial increase in reactive oxygen species 15 min after puromycin aminonucleoside. Nine days after induction of nephrosis, primarily superoxide anion and hydroxyl radical were found to contribute to increased reactive oxygen species. Despite oxidative stress, antioxidant enzymes were not induced in the course of nephrosis. On the contrary, catalase and glutathione peroxidase activities declined 9 d after puromycin aminonucleoside injection. The results indicate that a transient increase in glomerular reactive oxygen species is sufficient to induce the oxidative glomerular injury observed in this model and that the glomerulus may not necessarily respond to oxidative stress with an induction of antioxidant enzymes.
Gwinner
W
W
Department of Internal Medicine, Medical School Hannover, Germany.
Landmesser
U
U
Brandes
R P
RP
Kubat
B
B
Plasger
J
J
Eberhard
O
O
Koch
K M
KM
Olbricht
C J
CJ
D000818:Animals; D000903:Antibiotics, Antineoplastic; D000975:Antioxidants / Q000378:metabolism*; D002374:Catalase / Q000378:metabolism*; D046508:Culture Techniques; D004195:Disease Models, Animal; D015433:Glomerulonephritis, Membranous / Q000139:chemically induced / Q000378:metabolism* / Q000473:pathology; D005979:Glutathione Peroxidase / Q000378:metabolism*; D008297:Male; D008854:Microscopy, Electron; D011692:Puromycin Aminonucleoside; D012333:RNA, Messenger / Q000032:analysis*; D051381:Rats; D017207:Rats, Sprague-Dawley; D017382:Reactive Oxygen Species / Q000378:metabolism*; D012016:Reference Values; D013482:Superoxide Dismutase / Q000378:metabolism*
D000903:Antibiotics, Antineoplastic; D000975:Antioxidants; D012333:RNA, Messenger; D017382:Reactive Oxygen Species; D011692:Puromycin Aminonucleoside; D002374:Catalase; D005979:Glutathione Peroxidase; D013482:Superoxide Dismutase